Clinical Trial Update: Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) [Phase 2]

View source ↗

Summary

Open-label extension study of GB002 in adults with pulmonary arterial hypertension is ongoing, with the trial status listed as ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• GB002

Snippet

Sponsor: GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: ACTIVE_NOT_RECRUITING